Smulever Anabella, Pitoia Fabian
Division of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Córdoba 2351, 5th floor, Buenos Aires, Argentina.
Thyroid Res. 2023 Mar 13;16(1):6. doi: 10.1186/s13044-023-00148-6.
The detection of low-risk thyroid carcinoma has increased in recent decades, although disease-specific mortality remained without changes. The high prevalence of occult carcinomas in autopsy studies, and hence the underlying indolent course of this entity, prompted the emergence of active surveillance as an alternative approach to these tumors. This strategy aims to recognize the minority group of patients who will develop clinical progression and probably benefit from deferred surgery. Experience around the world has shown that during active surveillance these tumors are mostly unchanged in size, with very-slow growth and even a decrease in diameter. Moreover, the rates of lymph node metastases were low and easily handled by rescue surgery, and distant metastases have not been reported. Given the high prevalence of small thyroid carcinomas and the excellent outcomes for observation, active surveillance provides a safe and feasible alternative in properly selected patients with low-risk thyroid cancer.
近几十年来,低风险甲状腺癌的检出率有所上升,尽管疾病特异性死亡率并无变化。尸检研究中隐匿性癌的高患病率,以及该实体潜在的惰性病程,促使主动监测作为这些肿瘤的一种替代方法应运而生。这一策略旨在识别出少数会出现临床进展且可能从延迟手术中获益的患者群体。世界各地的经验表明,在主动监测期间,这些肿瘤大多大小不变,生长非常缓慢,甚至直径会缩小。此外,淋巴结转移率较低,通过补救手术易于处理,且尚未有远处转移的报道。鉴于小甲状腺癌的高患病率以及观察的良好结果,主动监测为经过适当选择的低风险甲状腺癌患者提供了一种安全可行的替代方案。